期刊文献+

小鼠骨髓内皮细胞无血清条件培养液及其超滤组分对粒巨噬系祖细胞生长的影响 被引量:1

EFFECTS OF BONE MARROW ENDOTHELIAL CELL CONDITIONED MEDIUM AND ITS ULTRAFILTRATION PREPARED COMPONENTS ON THE GROWTH OF CFU GM *
下载PDF
导出
摘要 本研究通过传代培养小鼠骨髓内皮细胞系细胞,收集无血清条件培养液(mBMECCM),将其作多级串联超滤,获得分子量大于10、3~10、1~3、05~1kD和小于05kD超滤组分。进行粒巨噬系造血祖细胞集落形成试验,检测了它们的作用。mBMECCM和3~10kD组分对粒巨噬系祖细胞(CFUGM)生长未见明显影响,而分子量大于10kD和05~1kD组分促进CFUGM的增殖,分子量1~3kD和小于05kD组分则抑制CFUGM的增殖。这4种超滤组分对CFUGM生长的效应均有剂量依赖性。这些结果提示,在体外培养条件下,小鼠骨髓内皮细胞分泌若干种活性成分。 In this study, we obtained the serum free conditioned medium from subcultures of murine bone marrow derived endothelial cell line which has been established recently by ourselves. And then, molecular weight (MW) >10 kD, 3~10 kD, 1~3 kD, 0 5~1 kD and <0 5 kD components were sifted out from the conditioned medium (mBMEC CM) by means of serial ultrafiltration. Assays of granulocyte macrophage colony forming cell (CFU GM) were performed to examine the effects of mBMEC CM and its ultrafiltration prepared components. It was not observed that mBMEC CM and MW 3~10 kD component had any significant influence on the growth of CFU GM. However, MW>10 kD and 0 5~1 kD components enhanced the proliferation of CFU GM, whereas MW 1~3 kD and <0 5 kD ones inhibited it. All these four components exerted their effects on the growth of CFU GM in dose dependent way. Our observations suggest that under the conditions of in vitro, murine bone marrow endothelial cells produce several active components which have promoting or inhibitory effects on the growth of CFU GM.
出处 《生理学报》 CAS CSCD 北大核心 1999年第6期645-650,共6页 Acta Physiologica Sinica
基金 国家自然科学基金!资助项目 (No 39370 2 71)
关键词 骨髓 内皮细胞 粒巨噬系祖细胞 调控因子 生长 bone marrow endothelial cell conditioned medium growth factor growth inhibitor CFU GM
  • 相关文献

参考文献2

  • 1Wang Q R,In Vitro Cell Dev Biol,1998年,34期,443页
  • 2Yan Y,Chin J Physiol Sci,1997年,13期,97页

同被引文献13

  • 1Chisi JE,Briscoe CV,Ezan E,Genet R,Riches AC,Wdzieczak-Bakala J.Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation.Br J Haematol 2000; 109(3):563-570.
  • 2Guigon M,Bonnet D,Cesaire R,Lemoine F,Najman A.Effects of small peptidic inhibitors of murine stem cells on human normal and malignant cells.Ann NY Acad Sci 1991;628:105-114.
  • 3Jackon JD,Yan Y,Ewel C,Talmadge JE.Activity of acetyln-Ser-Asp-Lys-Pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.Exp Hematol 1996; 24(3):475-481.
  • 4Frindel E,Guigon M.Inhibition of CFU entry into cycle by a bone marrow extract.Exp Hematol 1977; 5(1):74-76.
  • 5Bonnet D,Lemoine FM,Pontvert-Delucq S,Baillou C,Najman A,Guigon M.Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors.Blood 1993; 82(11):3307-3314.
  • 6Li J,Volkov L,Comte L,Herve P,Praloran V,Charbord P.Production and consumption of the tetrapeptide AcSDKP,a negative regulator of hematopoietic stem cells,by hematopoietic microenvironmental cells.Exp Hematol 1997; 25(2):140-146.
  • 7Volkov L,Quere P,Coudert F,Comte L,Antipov Y,Praloran V.The tetrapeptide AcSDKP,a negative regulator of cell cycle entry,inhibits the proliferation of human and chicken lymphocytes.Cell Immunol 1996; 168(2):302-306.
  • 8Pittenger MF,Mackay AM,Beck SC,Jaiswal RK,Douglas R,Mosca JD,Moorman MA,Simonetti DW,Craig S,Marshak DR.Multilinesge potential of adult human mesenchymal stem cells.Science 1999; 284(5411):143-147.
  • 9Bonnet D,Cesaire R,Lemoine F,Aoudjhane M,Najman A,Guigon M.The tetrapeptide AcSDKP,an inhibitor of the cell-cycle status for normal human hematopoietic progenitors,has no effect on leukemic cells.Exp Hematol 1992; 20(2):251-255.
  • 10Bogden AE,Moreau JP,Gamba-Vitalo C,Deschamps de Paillette E,Tubiana M,Frindel E,Carde P.Goralatide (AcSDKP),a negative growth regulator,protects the stem cell compartment during chemotherapy,enhancing the myelopoietic response to GM-CSF.Int J Cancer 1998; 76(1):38-46.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部